EUVIMEDEUVIMED entdecken
Crossref

Cutaneous leiomyosarcoma: a retrospective review of 45 cases

Sabrina Khan, Ruth Asher, William Perkins, Rubeta N Matin iD

Clinical and Experimental Dermatology · 19.12.2023 · 49 (1) · 2-8

DOI: 10.1093/ced/llad276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 18.08.2023. Verfasst von Sabrina Khan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Oxford University Hospitals NHS Foundation Trust, Oxford , UK. Hauptthemen laut MEDLINE: Skin Neoplasms, Leiomyosarcoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abstract Primary cutaneous leiomyosarcoma (LMS) is a rare soft tissue tumour type with two subtypes, dermal and subcutaneous. As deeper tumours confer a worse prognosis, they require a more aggressive approach. Conversely, a more conservative surgical approach for dermal LMS has been suggested. Few studies have comprehensively reported both clinical surgical and histological excision margins. Therefore, we sought to provide margin recommendations based on our experience and review of the existing literature. We undertook a retrospective case-note review (1998–2019) of cutaneous LMS management to establish histological/surgical margins using pathology/electronic patient records. The diagnosis was made and classified by an experienced dermatopathologist according to the World Health Organization classification. In the dermal LMS cohort (n = 35), mean peripheral and deep histological margins were 5.4 mm (range 0.5–20) and 5.6 mm (range 0.1–14.5), respectively. The incomplete excision rate was 31% (11 of 35). There were no recurrences. In the subcutaneous LMS cohort (n = 10), mean peripheral and deep histological margins were 5.7 mm (range 0.2–14) and 1.1 mm (range 0.2–1.7), respectively. The incomplete excision rate was 40% (4 of 10). The recurrence rate was 20% (2 of 10) despite achieving histological clearance after 1 year. One lung metastasis occurred 1 year following an adequately excised primary scalp LMS. Thus, for dermal LMS we propose a clinical margin of 5–10 mm (depending on lesion size) at the initial excision or at scar re-excision following involved/close histological peripheral and/or deep margins (i.e. < 1 mm). For subcutaneous LMS, we suggest a clinical margin of 15–20 mm (depending on lesion size) to achieve a peripheral histological clearance of 10 mm and negative deep margin (i.e. > 1 mm), down to the periosteum/fascia/muscle according to anatomical site. If this is not achieved, a re-excision would be recommended. However, prospective studies are needed for optimal guidance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsLeiomyosarcomaHumansRetrospective StudiesPrognosisSkinMargins of ExcisionNeoplasm Recurrence, Local

Autor:innen und Institutionen

  • Department of Dermatology, Oxford University Hospitals NHS Foundation Trust, Oxford , UK.
  • Department of Pathology, Cardiff and Vale University Health Board, Cardiff , UK.

ORCID-Profile: Rubeta N Matin

Zitieren

APA

Khan, S., Asher, R., Perkins, W., & Matin, R. N. (2023). Cutaneous leiomyosarcoma: a retrospective review of 45 cases. Clinical and Experimental Dermatology, 49(1), 2-8. https://doi.org/10.1093/ced/llad276

Vancouver

Khan S, Asher R, Perkins W, Matin RN. Cutaneous leiomyosarcoma: a retrospective review of 45 cases. Clinical and Experimental Dermatology. 2023;49(1):2-8. doi:10.1093/ced/llad276

BibTeX
@article{Khan2023,
  author = {Khan, Sabrina and Asher, Ruth and Perkins, William and Matin, Rubeta N},
  title = {Cutaneous leiomyosarcoma: a retrospective review of 45 cases},
  journal = {Clinical and Experimental Dermatology},
  year = {2023},
  volume = {49},
  number = {1},
  pages = {2--8},
  doi = {10.1093/ced/llad276}
}
Kostenlos starten →